Bank of New York Mellon
ANRO icon

Bank of New York Mellon’s Alto Neuroscience ANRO Stock Holding History

Bank of New York Mellon’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
+76,330
New +$1.77M ﹤0.01% 2943
2025
Q2 		– Sell
-49,545
Closed -$107K – 4287
2025
Q1 		$107K Sell
49,545
-2,726
-5% -$9.76K ﹤0.01% 3993
2024
Q4 		$221K Buy
52,271
+6,812
+15% +$42.5K ﹤0.01% 3915
2024
Q3 		$520K Buy
45,459
+21,902
+93% +$268K ﹤0.01% 3497
2024
Q2 		$252K Buy
+23,557
New +$307K ﹤0.01% 3882

Other funds holding ANRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Bank of New York Mellon's ANRO Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 76,330 shares worth $2.01M. The stake represents ﹤0.01% of the portfolio and ranks #2943 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in ANRO as recently as Q1 2025.

Bank of New York Mellon first reported a position in ANRO in Q2 2024 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Bank of New York Mellon held 76,330 shares of Alto Neuroscience worth $2.01M as of Q2 2026.
  • Alto Neuroscience was a new Bank of New York Mellon position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2943 holding.
  • Bank of New York Mellon first reported a position in Alto Neuroscience in Q2 2024 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.